Morgan Stanley’s Advent Technologies ADN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-2,272
| Closed | -$7.57K | – | 8201 |
|
|
2025
Q3 | $7.57K | Buy |
2,272
+13
| +0.6% | +$38 | ﹤0.01% | 6974 |
|
|
2025
Q2 | $4.7K | Sell |
2,259
-21
| -0.9% | -$54 | ﹤0.01% | 7053 |
|
|
2025
Q1 | $9.67K | Buy |
2,280
+30
| +1% | +$155 | ﹤0.01% | 6810 |
|
|
2024
Q4 | $11.3K | Sell |
2,250
-1,300
| -37% | -$5.38K | ﹤0.01% | 6761 |
|
|
2024
Q3 | $7.67K | Hold |
3,550
| – | – | ﹤0.01% | 6788 |
|
|
2024
Q2 | $10.8K | Sell |
3,550
-368
| -9% | -$1.45K | ﹤0.01% | 6656 |
|
|
2024
Q1 | $21.2K | Sell |
3,918
-1,108
| -22% | -$6.07K | ﹤0.01% | 6468 |
|
|
2023
Q4 | $33.6K | Sell |
5,026
-3,075
| -38% | -$35.4K | ﹤0.01% | 6488 |
|
|
2023
Q3 | $95.1K | Buy |
8,101
+5,361
| +196% | +$105K | ﹤0.01% | 5917 |
|
|
2023
Q2 | $48.4K | Sell |
2,740
-1,355
| -33% | -$32.7K | ﹤0.01% | 6223 |
|
|
2023
Q1 | $130K | Buy |
4,095
+1,882
| +85% | +$95K | ﹤0.01% | 5902 |
|
|
2022
Q4 | $120K | Sell |
2,213
-2,757
| -55% | -$171K | ﹤0.01% | 5896 |
|
|
2022
Q3 | $455K | Sell |
4,970
-14,620
| -75% | -$1.3M | ﹤0.01% | 5313 |
|
|
2022
Q2 | $1.48M | Buy |
19,590
+16,751
| +590% | +$1.01M | ﹤0.01% | 4747 |
|
|
2022
Q1 | $197K | Buy |
2,839
+1,998
| +238% | +$226K | ﹤0.01% | 5932 |
|
|
2021
Q4 | $177K | Sell |
841
-305
| -27% | -$76.1K | ﹤0.01% | 6134 |
|
|
2021
Q3 | $299K | Buy |
1,146
+641
| +127% | +$156K | ﹤0.01% | 5787 |
|
|
2021
Q2 | $146K | Buy |
+505
| New | +$168K | ﹤0.01% | 6172 |
|
|
2021
Q1 | – | Sell |
-519
| Closed | -$233K | – | 7473 |
|
|
2020
Q4 | $233K | Buy |
519
+515
| +12,875% | +$178K | ﹤0.01% | 5517 |
|
|
2020
Q3 | $1K | Buy |
+4
| New | +$1.24K | ﹤0.01% | 6637 |
|
|
2020
Q2 | – | Sell |
-2
| Closed | -$1K | – | 6582 |
|
|
2020
Q1 | $1K | Sell |
2
-206
| -99% | -$62.8K | ﹤0.01% | 6444 |
|
|
2019
Q4 | $63K | Buy |
208
+174
| +512% | +$52.6K | ﹤0.01% | 5793 |
|
|
2019
Q3 | $10K | Sell |
34
-11
| -24% | -$3.3K | ﹤0.01% | 6190 |
|
|
2019
Q2 | $14K | Buy |
45
+34
| +309% | +$10.1K | ﹤0.01% | 6035 |
|
|
2019
Q1 | $3K | Buy |
+11
| New | +$3.23K | ﹤0.01% | 6386 |
|
Other funds holding ADN
Morgan Stanley's ADN Position: Q4 2025 in Review
Morgan Stanley sold out of Advent Technologies (ADN) in Q4 2025, closing a stake of 2,272 shares — an estimated $7.57K sold.
Morgan Stanley first reported a position in ADN in Q1 2019 and held it in 25 quarters. The position peaked at $1.48M in Q2 2022. 1 fund tracked by Wall St. Rank holds ADN as of Q4 2025.
- Morgan Stanley reported no remaining Advent Technologies position as of Q4 2025 after selling out during the quarter.
- Morgan Stanley sold 2,272 Advent Technologies shares in Q4 2025, an estimated $7.57K.
- Morgan Stanley first reported a position in Advent Technologies in Q1 2019 and held it in 25 quarters.
- Morgan Stanley's Advent Technologies position peaked at $1.48M in Q2 2022.
- 1 fund tracked by Wall St. Rank held Advent Technologies as of Q4 2025.
Based on Morgan Stanley's 13F filing for Q4 2025, filed 13 Feb 2026.